We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Kenvue's Brand Strength and Innovation Strategy Support Growth
Read MoreHide Full Article
Key Takeaways
Kenvue's leading brands support resilient demand across Self Care, Skin Health and Essential Health.
Innovation, digital capabilities and portfolio optimization are key to strengthening Kenvue's growth.
Kenvue's productivity efforts aim to support margins while creating flexibility for brand investments.
Kenvue Inc. (KVUE - Free Report) holds a strong position in the consumer health market, backed by a portfolio of trusted brands, extensive global presence and continued investments in innovation. The company’s portfolio features well-established names, including Tylenol, Zyrtec, Nicorette, Neutrogena, Listerine, Aveeno, OGX and Johnson’s. The strength and broad recognition of these brands enable Kenvue to address evolving consumer needs while supporting sustainable growth opportunities across the global consumer health market.
Kenvue is focused on strengthening its portfolio around leading brands and attractive consumer health categories, supported by innovation, effective brand building and broad distribution capabilities. Its Self Care, Skin Health and Beauty, and Essential Health businesses provide exposure to diverse everyday health and wellness needs. The company continues to invest in its Power Brands through product innovation, marketing and consumer-focused offerings designed to respond to changing preferences and expand category opportunities.
The company remains focused on achieving growth by strengthening its leading brands, enhancing productivity and improving operational efficiency. Kenvue is pursuing innovation across its portfolio while simplifying its operations, optimizing its product mix and expanding the use of digital capabilities to drive better execution. Ongoing cost-saving and productivity initiatives are expected to support margins while providing greater flexibility to reinvest in its brands and pursue growth opportunities.
At its core, Kenvue is well-positioned to capitalize on resilient consumer demand for trusted, everyday health and personal care products, backed by a strong portfolio of iconic brands and a broad global presence. Brand strength, innovation, portfolio optimization, productivity initiatives and continued investment in consumer engagement provide important support for KVUE’s growth and long-term value creation.
KVUE’s Price Performance, Valuation & Estimates
Shares of Kenvue have gained 5.6% in the past six months compared with the industry’s decline of 3.1%.
Image Source: Zacks Investment Research
From a valuation standpoint, KVUE trades at a forward price-to-earnings ratio of 15.57X compared with the industry’s average of 18.66X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for KVUE’s 2026 and 2027 earnings per share (EPS) indicates year-over-year growth of 5.6% and 7.6%, respectively. The company’s EPS estimate for 2026 has moved south while that of 2027 has been stable in the past 30 days.
Image Source: Zacks Investment Research
Kenvue stock currently carries a Zacks Rank #3 (Hold).
The Zacks Consensus Estimate for Chefs' Warehouse's current financial-year sales indicates growth of 10.6% from the prior-year level. CHEF delivered a trailing four-quarter earnings surprise of 30.4%, on average.
Darling Ingredients Inc. (DAR - Free Report) , which produces sustainable natural ingredients derived from edible and inedible bio-nutrients, currently sports a Zacks Rank of 1.
The consensus estimate for Darling Ingredients’ current financial-year sales is expected to rise 12.8% from the year-ago reported figure. DAR delivered a trailing four-quarter earnings surprise of 38.9%, on average.
Utz Brands, Inc. (UTZ - Free Report) , which is a leading manufacturer of a diverse portfolio of salty snacks, currently carries a Zacks Rank #2 (Buy). UTZ delivered a trailing four-quarter earnings surprise of 1.8%, on average.
The Zacks Consensus Estimate for UTZ’s current financial-year sales indicates a jump of 3.7% from the year-ago number.
View the Zacks #1 Rank List
Image: Bigstock
Kenvue's Brand Strength and Innovation Strategy Support Growth
Key Takeaways
Kenvue Inc. (KVUE - Free Report) holds a strong position in the consumer health market, backed by a portfolio of trusted brands, extensive global presence and continued investments in innovation. The company’s portfolio features well-established names, including Tylenol, Zyrtec, Nicorette, Neutrogena, Listerine, Aveeno, OGX and Johnson’s. The strength and broad recognition of these brands enable Kenvue to address evolving consumer needs while supporting sustainable growth opportunities across the global consumer health market.
Kenvue is focused on strengthening its portfolio around leading brands and attractive consumer health categories, supported by innovation, effective brand building and broad distribution capabilities. Its Self Care, Skin Health and Beauty, and Essential Health businesses provide exposure to diverse everyday health and wellness needs. The company continues to invest in its Power Brands through product innovation, marketing and consumer-focused offerings designed to respond to changing preferences and expand category opportunities.
The company remains focused on achieving growth by strengthening its leading brands, enhancing productivity and improving operational efficiency. Kenvue is pursuing innovation across its portfolio while simplifying its operations, optimizing its product mix and expanding the use of digital capabilities to drive better execution. Ongoing cost-saving and productivity initiatives are expected to support margins while providing greater flexibility to reinvest in its brands and pursue growth opportunities.
At its core, Kenvue is well-positioned to capitalize on resilient consumer demand for trusted, everyday health and personal care products, backed by a strong portfolio of iconic brands and a broad global presence. Brand strength, innovation, portfolio optimization, productivity initiatives and continued investment in consumer engagement provide important support for KVUE’s growth and long-term value creation.
KVUE’s Price Performance, Valuation & Estimates
Shares of Kenvue have gained 5.6% in the past six months compared with the industry’s decline of 3.1%.
Image Source: Zacks Investment Research
From a valuation standpoint, KVUE trades at a forward price-to-earnings ratio of 15.57X compared with the industry’s average of 18.66X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for KVUE’s 2026 and 2027 earnings per share (EPS) indicates year-over-year growth of 5.6% and 7.6%, respectively. The company’s EPS estimate for 2026 has moved south while that of 2027 has been stable in the past 30 days.
Image Source: Zacks Investment Research
Kenvue stock currently carries a Zacks Rank #3 (Hold).
Key Consumer Staple Picks
The Chefs' Warehouse, Inc. (CHEF - Free Report) , which is a distributor of specialty food products in the United States, currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Chefs' Warehouse's current financial-year sales indicates growth of 10.6% from the prior-year level. CHEF delivered a trailing four-quarter earnings surprise of 30.4%, on average.
Darling Ingredients Inc. (DAR - Free Report) , which produces sustainable natural ingredients derived from edible and inedible bio-nutrients, currently sports a Zacks Rank of 1.
The consensus estimate for Darling Ingredients’ current financial-year sales is expected to rise 12.8% from the year-ago reported figure. DAR delivered a trailing four-quarter earnings surprise of 38.9%, on average.
Utz Brands, Inc. (UTZ - Free Report) , which is a leading manufacturer of a diverse portfolio of salty snacks, currently carries a Zacks Rank #2 (Buy). UTZ delivered a trailing four-quarter earnings surprise of 1.8%, on average.
The Zacks Consensus Estimate for UTZ’s current financial-year sales indicates a jump of 3.7% from the year-ago number.